The Impact and Clinical Prediction of Hyperglycemia During Parenteral Nutrition for Nondiabetic Patients After Gastrectomy for Gastric Cancer

Background and PurposeHyperglycemia (HG) is associated with increased postoperative complications. This study aims to evaluate the effect of HG during supplemental parenteral nutrition (SPN) on short-term prognosis in non-diabetic patients undergoing gastrectomy for cancer and to analyse the risk fa...

Full description

Bibliographic Details
Main Authors: Ning Lan, Xiaohua Chen, Ying Lu, Yujie Zhou, Fei Kong, Yining Zhao, Fuzhi Jiao, Lin Zhang, Wenzhen Yuan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2022.807841/full
_version_ 1818330545018372096
author Ning Lan
Xiaohua Chen
Ying Lu
Yujie Zhou
Fei Kong
Yining Zhao
Fuzhi Jiao
Lin Zhang
Wenzhen Yuan
author_facet Ning Lan
Xiaohua Chen
Ying Lu
Yujie Zhou
Fei Kong
Yining Zhao
Fuzhi Jiao
Lin Zhang
Wenzhen Yuan
author_sort Ning Lan
collection DOAJ
description Background and PurposeHyperglycemia (HG) is associated with increased postoperative complications. This study aims to evaluate the effect of HG during supplemental parenteral nutrition (SPN) on short-term prognosis in non-diabetic patients undergoing gastrectomy for cancer and to analyse the risk factors and prevention methods for HG.MethodsA total of 359 patients were divided into three groups according to blood glucose (BG) during SPN: normoglycemic patients ( ≤ 125 mg/dL), mild HG (125~200 mg/dL), and severe HG (>200 mg/dL). The effect of BG on postoperative short-term outcomes was analyzed. Multivariate regression was performed to investigate influencing factors for severe HG. The safety and efficacy of insulin addition to total nutrient admixture (TNA) for the prevention and management of HG were assessed by propensity score matching (PSM). In addition, regression analysis was performed in the noninsulin group to investigate the predictive factors of severe HG, and a nomogram was plotted.ResultsThe postoperative complication rate was 18.9%, but it was significantly higher in patients with severe HG than in mild HG and normoglycemic patients (25.2, 15.0, and 10.0%, respectively, p < 0.05). Multivariate logistic regression analysis showed that anemia, myosteatosis, higher postoperative capillary blood glucose (CBG) before TNA infusion, and insulin in the TNA were independent influencing factors for severe HG. Based on the above factors, 75 pairs of patients (insulin group and non-insulin group) with comparable baseline data were successfully matched by PSM. The HG incidence and the glycemic fluctuation were significantly improved through 1 U insulin/6 g glucose (1/6 scheme) to TNA. A nomogram containing hemoglobin, skeletal muscle radiodensity, pre-SPN CBG, and pTNM stage with good predictive efficacy (C-index: 0.750) was constructed based on the noninsulin group.ConclusionPoor postoperative glycemic control was related to worse outcomes in non-diabetic patients undergoing gastrectomy for cancer. Pre-operative anemia, myosteatosis, and high postoperative CBG before TNA infusion are risk factors for severe HG. Insulin in TNA can improve the blood glucose control of patients. Our proposed nomogram rendered an individualized predictive tool for HG during SPN, which helps screen high-risk patients requiring insulin therapy. Future studies with larger samples are needed to develop a complete insulin application protocol for SPN.
first_indexed 2024-12-13T13:05:39Z
format Article
id doaj.art-859a006d1edd493db16a65909378ae53
institution Directory Open Access Journal
issn 2296-861X
language English
last_indexed 2024-12-13T13:05:39Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj.art-859a006d1edd493db16a65909378ae532022-12-21T23:44:51ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2022-02-01910.3389/fnut.2022.807841807841The Impact and Clinical Prediction of Hyperglycemia During Parenteral Nutrition for Nondiabetic Patients After Gastrectomy for Gastric CancerNing Lan0Xiaohua Chen1Ying Lu2Yujie Zhou3Fei Kong4Yining Zhao5Fuzhi Jiao6Lin Zhang7Wenzhen Yuan8The First School of Clinical Medicine, Lanzhou University, Lanzhou, ChinaDepartment of Radiation Oncology, The First Hospital of Lanzhou University, Lanzhou, ChinaThe First School of Clinical Medicine, Lanzhou University, Lanzhou, ChinaThe First School of Clinical Medicine, Lanzhou University, Lanzhou, ChinaThe First School of Clinical Medicine, Lanzhou University, Lanzhou, ChinaThe First School of Clinical Medicine, Lanzhou University, Lanzhou, ChinaThe First School of Clinical Medicine, Lanzhou University, Lanzhou, ChinaCenter for Family Medicine and Integrative Health Care, Beijing United Family Hospital, Beijing, ChinaDepartment of Surgical Oncology, The First Hospital of Lanzhou University, Lanzhou, ChinaBackground and PurposeHyperglycemia (HG) is associated with increased postoperative complications. This study aims to evaluate the effect of HG during supplemental parenteral nutrition (SPN) on short-term prognosis in non-diabetic patients undergoing gastrectomy for cancer and to analyse the risk factors and prevention methods for HG.MethodsA total of 359 patients were divided into three groups according to blood glucose (BG) during SPN: normoglycemic patients ( ≤ 125 mg/dL), mild HG (125~200 mg/dL), and severe HG (>200 mg/dL). The effect of BG on postoperative short-term outcomes was analyzed. Multivariate regression was performed to investigate influencing factors for severe HG. The safety and efficacy of insulin addition to total nutrient admixture (TNA) for the prevention and management of HG were assessed by propensity score matching (PSM). In addition, regression analysis was performed in the noninsulin group to investigate the predictive factors of severe HG, and a nomogram was plotted.ResultsThe postoperative complication rate was 18.9%, but it was significantly higher in patients with severe HG than in mild HG and normoglycemic patients (25.2, 15.0, and 10.0%, respectively, p < 0.05). Multivariate logistic regression analysis showed that anemia, myosteatosis, higher postoperative capillary blood glucose (CBG) before TNA infusion, and insulin in the TNA were independent influencing factors for severe HG. Based on the above factors, 75 pairs of patients (insulin group and non-insulin group) with comparable baseline data were successfully matched by PSM. The HG incidence and the glycemic fluctuation were significantly improved through 1 U insulin/6 g glucose (1/6 scheme) to TNA. A nomogram containing hemoglobin, skeletal muscle radiodensity, pre-SPN CBG, and pTNM stage with good predictive efficacy (C-index: 0.750) was constructed based on the noninsulin group.ConclusionPoor postoperative glycemic control was related to worse outcomes in non-diabetic patients undergoing gastrectomy for cancer. Pre-operative anemia, myosteatosis, and high postoperative CBG before TNA infusion are risk factors for severe HG. Insulin in TNA can improve the blood glucose control of patients. Our proposed nomogram rendered an individualized predictive tool for HG during SPN, which helps screen high-risk patients requiring insulin therapy. Future studies with larger samples are needed to develop a complete insulin application protocol for SPN.https://www.frontiersin.org/articles/10.3389/fnut.2022.807841/fullgastrectomyhyperglycemiacomplicationinsulinglycemic fluctuation
spellingShingle Ning Lan
Xiaohua Chen
Ying Lu
Yujie Zhou
Fei Kong
Yining Zhao
Fuzhi Jiao
Lin Zhang
Wenzhen Yuan
The Impact and Clinical Prediction of Hyperglycemia During Parenteral Nutrition for Nondiabetic Patients After Gastrectomy for Gastric Cancer
Frontiers in Nutrition
gastrectomy
hyperglycemia
complication
insulin
glycemic fluctuation
title The Impact and Clinical Prediction of Hyperglycemia During Parenteral Nutrition for Nondiabetic Patients After Gastrectomy for Gastric Cancer
title_full The Impact and Clinical Prediction of Hyperglycemia During Parenteral Nutrition for Nondiabetic Patients After Gastrectomy for Gastric Cancer
title_fullStr The Impact and Clinical Prediction of Hyperglycemia During Parenteral Nutrition for Nondiabetic Patients After Gastrectomy for Gastric Cancer
title_full_unstemmed The Impact and Clinical Prediction of Hyperglycemia During Parenteral Nutrition for Nondiabetic Patients After Gastrectomy for Gastric Cancer
title_short The Impact and Clinical Prediction of Hyperglycemia During Parenteral Nutrition for Nondiabetic Patients After Gastrectomy for Gastric Cancer
title_sort impact and clinical prediction of hyperglycemia during parenteral nutrition for nondiabetic patients after gastrectomy for gastric cancer
topic gastrectomy
hyperglycemia
complication
insulin
glycemic fluctuation
url https://www.frontiersin.org/articles/10.3389/fnut.2022.807841/full
work_keys_str_mv AT ninglan theimpactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT xiaohuachen theimpactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT yinglu theimpactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT yujiezhou theimpactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT feikong theimpactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT yiningzhao theimpactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT fuzhijiao theimpactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT linzhang theimpactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT wenzhenyuan theimpactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT ninglan impactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT xiaohuachen impactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT yinglu impactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT yujiezhou impactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT feikong impactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT yiningzhao impactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT fuzhijiao impactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT linzhang impactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer
AT wenzhenyuan impactandclinicalpredictionofhyperglycemiaduringparenteralnutritionfornondiabeticpatientsaftergastrectomyforgastriccancer